IL-12 and PD-1 peptide combination gene therapy for the treatment of melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

IL-12 and PD-1 peptide combination gene therapy for the treatment of melanoma

Published:2024-09 Issue:3 Volume:35 Page:102267
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Heller Loree C.^ORCID,Shi Guilan,Sales Conniff Amanda,Singh Julie,Mannarino Samantha,Synowiec Jody,Heller Richard

Funder

University of South Florida

Publisher

Elsevier BV

Reference44 articles.

1. Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial;Robert;Lancet,2014

2. Nivolumab in previously untreated melanoma without BRAF mutation;Robert;N. Engl. J. Med.,2015

3. Death or Debt? National Estimates of Financial Toxicity in Persons with Newly-Diagnosed Cancer;Gilligan;Am. J. Med.,2018

4. Early Returns From the Era of Precision Medicine;Cutler;JAMA,2020

5. Disparities in cancer care-A call to action;Abuali;Cancer Cell,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP